Home > Publications database > Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients. > print |
001 | 167532 | ||
005 | 20240326154322.0 | ||
024 | 7 | _ | |a 10.1038/s41467-021-21297-y |2 doi |
024 | 7 | _ | |a pmid:33602930 |2 pmid |
024 | 7 | _ | |a altmetric:100388269 |2 altmetric |
037 | _ | _ | |a DKFZ-2021-00397 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 500 |
100 | 1 | _ | |a Xydia, Maria |0 P:(DE-He78)d3f0a48c15b355dfeae29fd5137d8bcb |b 0 |e First author |
245 | _ | _ | |a Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients. |
260 | _ | _ | |a [London] |c 2021 |b Nature Publishing Group UK |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1711463791_21797 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #EA:D015#LA:D015# |
520 | _ | _ | |a Regulatory CD4+ T cells (Treg) prevent tumor clearance by conventional T cells (Tconv) comprising a major obstacle of cancer immune-surveillance. Hitherto, the mechanisms of Treg repertoire formation in human cancers remain largely unclear. Here, we analyze Treg clonal origin in breast cancer patients using T-Cell Receptor and single-cell transcriptome sequencing. While Treg in peripheral blood and breast tumors are clonally distinct, Tconv clones, including tumor-antigen reactive effectors (Teff), are detected in both compartments. Tumor-infiltrating CD4+ cells accumulate into distinct transcriptome clusters, including early activated Tconv, uncommitted Teff, Th1 Teff, suppressive Treg and pro-tumorigenic Treg. Trajectory analysis suggests early activated Tconv differentiation either into Th1 Teff or into suppressive and pro-tumorigenic Treg. Importantly, Tconv, activated Tconv and Treg share highly-expanded clones contributing up to 65% of intratumoral Treg. Here we show that Treg in human breast cancer may considerably stem from antigen-experienced Tconv converting into secondary induced Treg through intratumoral activation. |
536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Rahbari, Raheleh |0 0000-0002-1839-7785 |b 1 |
700 | 1 | _ | |a Ruggiero, Eliana |0 P:(DE-He78)606957afb35b517e3fdd526379767c48 |b 2 |
700 | 1 | _ | |a Macaulay, Iain |b 3 |
700 | 1 | _ | |a Tarabichi, Maxime |b 4 |
700 | 1 | _ | |a Lohmayer, Robert |b 5 |
700 | 1 | _ | |a Wilkening, Stefan |0 P:(DE-He78)928f784868a4b5ff301367ecda92f152 |b 6 |
700 | 1 | _ | |a Michels, Tillmann |b 7 |
700 | 1 | _ | |a Brown, Daniel |b 8 |
700 | 1 | _ | |a Vanuytven, Sebastiaan |b 9 |
700 | 1 | _ | |a Mastitskaya, Svetlana |0 0000-0002-4819-2908 |b 10 |
700 | 1 | _ | |a Laidlaw, Sean |0 0000-0001-7658-1428 |b 11 |
700 | 1 | _ | |a Grabe, Niels |b 12 |
700 | 1 | _ | |a Pritsch, Maria |0 P:(DE-HGF)0 |b 13 |
700 | 1 | _ | |a Fronza, Raffaele |0 P:(DE-He78)c2585457f370249465a2080111937cf5 |b 14 |
700 | 1 | _ | |a Hexel, Klaus |0 P:(DE-He78)8e8f777853496a781f0c651d77c36abf |b 15 |u dkfz |
700 | 1 | _ | |a Schmitt, Steffen |0 P:(DE-He78)9743d171a21db4cf055df4dcf0153153 |b 16 |u dkfz |
700 | 1 | _ | |a Müller-Steinhardt, Michael |b 17 |
700 | 1 | _ | |a Halama, Niels |b 18 |
700 | 1 | _ | |a Domschke, Christoph |b 19 |
700 | 1 | _ | |a Schmidt, Manfred |0 P:(DE-He78)b91bec47a4148ba68a58ab292d5860f2 |b 20 |u dkfz |
700 | 1 | _ | |a von Kalle, Christof |0 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de |b 21 |u dkfz |
700 | 1 | _ | |a Schütz, Florian |b 22 |
700 | 1 | _ | |a Voet, Thierry |b 23 |
700 | 1 | _ | |a Beckhove, Philipp |0 P:(DE-He78)1732377f6242a18280bc6aaa196988d1 |b 24 |e Last author |
773 | _ | _ | |a 10.1038/s41467-021-21297-y |g Vol. 12, no. 1, p. 1119 |0 PERI:(DE-600)2553671-0 |n 1 |p 1119 |t Nature Communications |v 12 |y 2021 |x 2041-1723 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:167532 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)d3f0a48c15b355dfeae29fd5137d8bcb |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)606957afb35b517e3fdd526379767c48 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)928f784868a4b5ff301367ecda92f152 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 14 |6 P:(DE-He78)c2585457f370249465a2080111937cf5 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)8e8f777853496a781f0c651d77c36abf |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)9743d171a21db4cf055df4dcf0153153 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 P:(DE-He78)b91bec47a4148ba68a58ab292d5860f2 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Functional and structural genomics |x 0 |
914 | 1 | _ | |y 2021 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT COMMUN : 2018 |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2020-08-25 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Peer review |d 2020-08-25 |
915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2020-08-25 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2020-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-08-25 |
915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b NAT COMMUN : 2018 |d 2020-08-25 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2020-08-25 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2020-08-25 |
920 | 1 | _ | |0 I:(DE-He78)D015-20160331 |k D015 |l Translationale Immunologie |x 0 |
920 | 1 | _ | |0 I:(DE-He78)W220-20160331 |k W220 |l Zytometrie |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)D015-20160331 |
980 | _ | _ | |a I:(DE-He78)W220-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|